Chronotherapy in Inflammatory Bowel Disease: Biological Rationale, Human Evidence, and a Clinical Implementation Framework
Digestive Diseases and Sciences · 2026
DOI: 10.1007/s10620-026-10196-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Digestive Diseases and Sciences, 2026. Verfasst von Khaled H Husain und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Connecticut, Farmington, CT, USA. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Circadian Rhythm, Chronotherapy. Die Arbeit nennt 87 Literaturangaben.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a chronic condition driven by a dysregulated immune response to the gut microbiome in genetically susceptible individuals. This process may be influenced by the circadian rhythm, the body's internal 24-h clock that coordinates physiology with the day-night cycle. Disruption of this rhythm, whether from behavior or intrinsic dysfunction, can disturb intestinal homeostasis and promote inflammation. Chronotherapy applies this concept clinically by aligning medical treatment with circadian timing to optimize efficacy and reduce adverse effects. There is growing evidence suggesting the importance of this approach for drug metabolism, immune activity, and symptom patterns, offering a new dimension of personalization beyond medication choice alone. This review summarizes the biological links between circadian regulation and intestinal inflammation, highlights emerging human data supporting time-based treatment strategies, and proposes a practical framework for integrating chronotherapy into routine IBD management. By considering when a therapy is delivered in addition to what therapy should be used, clinicians may enhance treatment response, limit toxicity, and improve overall disease control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Connecticut, Farmington, CT, USA.
- Department of Internal Medicine, CMH Kharian Medical College, Kharian, Pakistan.
- Department of Gastroenterology and Hepatology, University of Connecticut, Farmington, CT, USA. hvaziri@uchc.edu.
Zitieren
APA
Husain, K. H., Khan, H., Thakkar, B., Bungish, M., & Vaziri, H. (2026). Chronotherapy in Inflammatory Bowel Disease: Biological Rationale, Human Evidence, and a Clinical Implementation Framework. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-026-10196-1
Vancouver
Husain KH, Khan H, Thakkar B, Bungish M, Vaziri H. Chronotherapy in Inflammatory Bowel Disease: Biological Rationale, Human Evidence, and a Clinical Implementation Framework. Digestive Diseases and Sciences. 2026. doi:10.1007/s10620-026-10196-1
BibTeX
@article{Husain2026,
author = {Husain, Khaled H and Khan, Hira and Thakkar, Bianca and Bungish, Musa and Vaziri, Haleh},
title = {Chronotherapy in Inflammatory Bowel Disease: Biological Rationale, Human Evidence, and a Clinical Implementation Framework},
journal = {Digestive Diseases and Sciences},
year = {2026},
doi = {10.1007/s10620-026-10196-1}
}
EUVIMED